ArticleAtencion primaria2017

[Lixisenatide in patients with type 2 diabetes and obesity: Beyond glycaemic control].

M Mar Roca-Rodríguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.